Home › Funds › KVP Capital Advisors, LP › EOLS

KVP Capital Advisors, LP position in EOLS

EVOLUS INC · Health Care

KVP Capital Advisors, LP reported holding 150,000 shares of EOLS (EVOLUS INC) in its Q2 2026 13F filing — a position valued at US$1.0M, representing 0.76% of its reported portfolio and ranking #33 among its reported holdings. KVP Capital Advisors, LP first reported this position in Q2 2026.

Latest position (Q2 2026)150.00K sh
Reported value held$1.04M
Portfolio Weight0.76%
First reportedQ2 2026
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How KVP Capital Advisors, LP's EOLS position evolved

KVP Capital Advisors, LP first disclosed a stake in EOLS in Q2 2026 at 150,000 shares (US$1.0M).

Quarter by quarter

QuarterSharesValueChange
Q2 2026 150.00K $1.04M New

About EOLS and 13F data

EOLS (EVOLUS INC) is a Health Care company. 22 other funds we track also report a position in EOLS — the largest reported positions include Nantahala Capital Management, LLC (US$38.9M), BRAIDWELL LP (US$21.9M), Frazier Life Sciences Management, L.P. (US$18.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EOLS

All EOLS fund holders →

FAQ

How long has KVP Capital Advisors, LP held EOLS?

KVP Capital Advisors, LP has disclosed EOLS holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is KVP Capital Advisors, LP's current position in EOLS?

As of Q2 2026, KVP Capital Advisors, LP holds 150.00K shares of EOLS (EVOLUS INC), valued at $1.04M, representing 0.76% of its reported portfolio and ranking #33.

Has KVP Capital Advisors, LP been buying or selling EOLS?

In the latest 13F filing (Q2 2026), KVP Capital Advisors, LP newly opened its position in EOLS.

Which other funds hold EOLS?

Other major institutional holders of EOLS include Nantahala Capital Management, LLC, BRAIDWELL LP, Frazier Life Sciences Management, L.P., among 22 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.